ICU Medical CH-70SRecalls & reported problems
Icu Medical, Inc. · ChemoClave™ Vented Vial Spike, 20mm · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00840619070663), received between May 4, 2022 and May 4, 2022 — classified as 1 malfunction.
The most frequently reported specific device problem is “Fluid/Blood Leak” (1 report).
9 other recalls cover devices cleared under the same FDA submission (K173477); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Fluid/Blood Leak1
Patient problems
- Chemical Exposure1
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 4, 2022Fluid/Blood Leak; Fluid/Blood Leak
THE EVENT OCCURRED ON AN UNSPECIFIED DATE AND INVOLVED A CHEMOCLAVE® VENTED VIAL SPIKE, 20MM. THE CUSTOMER REPORTED LEAKAGE WHICH OCCURRED THROUGH THE FILTER DURING THE WITHDRAWAL OF A CYTOTOXIC DRUG FROM THE VIAL. THE EVENT OCCURRED DURING PREPARATION (SPANNING TWO MINUTES OF USE) OF AN INFUSION BAG. THE REPORTED ISSUE WAS DETECTED PRIOR TO PATIENT USE. THE DEVICE WAS NOT CHANGED OUT OR REPLACED WITH NO FURTHER PROBLEMS ENCOUNTERED. ALTHOUGH THERE WAS NO PATIENT INVOLVEMENT, NO SERIOUS INJURY/DEATH, NO MEDICAL/SURGICAL INTERVENTION REQUIRED, NO DELAY IN CRITICAL THERAPY AND NO ADVERSE OPERATOR CONSEQUENCES, THERE WAS AN UNPROTECTED EXPOSURE TO CYTOTOXIC CHEMOTHERAPY REPORTED.
Patient problems: Chemical Exposure; No Clinical Signs, Symptoms or Conditions
MAUDE report 14283125 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K173477. One submission often covers many models, so check the product and lot details in each record.
- Z-3161-2026 · May 12, 2026 · Open, ClassifiedIV Sets with drip chambers
- Z-3159-2026 · May 12, 2026 · Open, ClassifiedOncology sets with drip chambers
- Z-1579-2021 · Mar 16, 2021 · Open, ClassifiedREF CH3020 40" (102 cm) Appx. 4.8 ml, 20 Drop Admin Set w/In-Line Chamber, 2 Spiros", Hanger - Product Usage: provides access for the administration of fluids from a container to a
- Z-1576-2021 · Mar 16, 2021 · Open, ClassifiedREF CH2020 20mL Syringe w/Spinning Spiros, Red Cap - Product Usage: provides access for the administration of fluids from a container to a patient s vascular system through the adm
- Z-1577-2021 · Mar 16, 2021 · Open, ClassifiedREF CH2060 60mL Syringe w/Spinning Spiros, Red Cap - Product Usage: provides access for the administration of fluids from a container to a patient s vascular system through the adm
- Z-1580-2021 · Mar 16, 2021 · Open, ClassifiedREF CH3625 5" (13 cm) Appx 0.50 ml, Smallbore Trifuse Ext Set w/3 ChemoClave (Purple, Green Rings), Spiros w/Red Cap, 3 Clamps - Product Usage: provides access for the administrat
- Z-1578-2021 · Mar 16, 2021 · Open, ClassifiedREF CH3011 30" (76 cm) Appx 3.3 mL, 20 Drop Admin Set w/Integrated ChemoClave Drip Chamber, Spiros w/Red Cap, Bag Hanger - Product Usage: provides access for the administration o
- Z-0704-2021 · Aug 31, 2020 · Open, Classified3mL Syringe w/Spinning Spiros, Red Cap, REF: CH2003; 5mL Syringe w/Spinning Spiros, Red Cap, REF: CH2005; 10mL Syringe w/Spinning Spiros, Red Cap, REF: CH2010; 20mL Syringe w/Spinn
- Z-0248-2021 · Jul 6, 2020 · Terminated6.5 IN (17 cm) APPX 0.78 ml, Ext Set w/Clave Clear, Clave 4-Way Stopcock, Spiros Red Cap;1 unit per pouch, 50 pouches per case. UDI:(01)10887709098878(17)241201(30)50(10)4493149.
Other Closed antineoplastic and hazardous drug reconstitution and transfer system devices
- BD PhaSeal 515003BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall183 reports
- BD PhaSeal 515056BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall159 reports
- BD PhaSeal Optima 515070BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall154 reports
- Alaris 10012241-0500BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall138 reports
- BD PhaSeal 515005BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall128 reports
- ICU Medical CL3011Icu Medical, Inc. · Closed antineoplastic and hazardous drug reconstitution and transfer system3 recalls26 reports
- BD PhaSeal Optima 515052BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall114 reports
- ICU Medical CL3511Icu Medical, Inc. · Closed antineoplastic and hazardous drug reconstitution and transfer system3 recalls6 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page